William Blair Investment Management, LLC Biomarin Pharmaceutical Inc Transaction History

William Blair Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $36.7 Million - $47.8 Million	-482,850 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $7.37 Million - $8.78 Million	-94,826 Reduced 16.42%	482,850 $39.1 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $33.3 Million - $39.2 Million	-412,585 Reduced 41.66%	577,676 $51.5 Million
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $79.8 Million - $94 Million	990,261	990,261 $92.2 Million

633

184M

1.67M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on William Blair Investment Management, LLC with notifications on news.